SCHEMBL4876581

SCHEMBL4876581

Nc1nc(O)c2c(n1)-c1ccccc1CCCC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.54
BCHE P06276 2/20 0.52
ADORA1 P30542 2/20 0.50
ADORA2A P29274 1/20 0.50
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
HRH3 Q9Y5N1 2/20 0.48
HRH2 P25021 1/20 0.48
HRH1 P35367 1/20 0.48
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
RECQL P46063 1/20 0.46
RAB9A P51151 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDR P35968 3/20 0.45
ACHE P22303 1/20 0.44
NOS3 P29474 1/20 0.41
DYRK1A Q13627 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2167222 0.97 HRH4 (0.57) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL4588982 0.91 HRH4 (0.57) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL14197519 0.81 HRH4 (0.60) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL4868863 0.79 HRH4 (0.42) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL3341967 0.79 BCHE (0.59) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL4877385 0.78 HRH4 (0.62) HRH4BCHEADORA2AHRH3HRH2
SCHEMBL3144155 0.77 HRH4 (0.38) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL4869098 0.75 BCHE (0.46) HRH4BCHEKDM4EALDH1A1HRH3
SCHEMBL604768 0.74 HRH4 (0.79) HRH4BCHEADORA1ADORA2AKDM4E
SCHEMBL4879618 0.74 POLB (0.47) HRH4BCHEADORA1ADORA2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives DPYD, TYMS, UMPS HRH4 3013/4885BCHE 1235/4885ADORA1 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.